Boehringer Ingelheim has licensed Synaffix B.V.’s ADC technology, significantly bolstering its ADC portfolio with the goal of ...
Alchemab Therapeutics, a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies ...
Samsung Biologics, a global contract development and manufacturing organization (CDMO), has extended its collaboration with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback